Updates
General Updates
Cipla LimitedCIPLA · Filed with the exchange
Cipla's subsidiary InvaGen's USFDA inspection at its Central Islip facility is classified as Voluntary Action Indicated (VAI). This signals no immediate regulatory enforcement action, a positive development for operations.
No comments yet. Be the first.